Successful DNA immunisation of rats against fasciolosis.

Abstract:

:The liver fluke Fasciola hepatica contributes to great economic and health losses in the cattle industry in many countries, including Poland. Unfortunately, no vaccine against fasciolosis is commercially available. We have designed a DNA vaccine and tested it in rats. Groups of male or female rats received one intramuscular injection of 50 microg of a pcDNA 3.1 vector carrying cDNA encoding for a cysteine proteinase of F. hepatica. The plasmid was diluted in saline containing 0.05% bupivacaine. Control rats were injected with empty plasmid or not injected at all. All rats were challenged with 45 metacercariae of the fluke on day 28 of the experiment. Seven weeks after the challenge infection fluke burdens were evaluated in vaccinated and control rats. Male rats vaccinated with cysteine proteinase cDNA revealed 100% protection against F. hepatica infection. Females immunised in the same way exhibited the reduction of fluke burden by 74%.

journal_name

Vaccine

journal_title

Vaccine

authors

Kofta W,Mieszczanek J,Płucienniczak G,Wedrychowicz H

doi

10.1016/s0264-410x(00)00095-5

subject

Has Abstract

pub_date

2000-07-01 00:00:00

pages

2985-90

issue

26

eissn

0264-410X

issn

1873-2518

pii

S0264410X00000955

journal_volume

18

pub_type

杂志文章

相关文献

VACCINE文献大全
  • Production of antibodies and antibody fragments in plants.

    abstract::Our current knowledge allows the generation of transgenic plants that efficiently produce heterologous proteins from plant, bacterial, fungal or animal origin. Among all types of recombinant proteins, antibodies are particularly attractive because of their ability to specifically recognize and bind virtually any type ...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/s0264-410x(00)00514-4

    authors: Peeters K,De Wilde C,De Jaeger G,Angenon G,Depicker A

    更新日期:2001-03-21 00:00:00

  • Immune effects of the vaccine of live attenuated Aeromonas hydrophila screened by rifampicin on common carp (Cyprinus carpio L).

    abstract::Aeromonas hydrophila, as a strong Gram-negative bacterium, can infect a wide range of freshwater fish, including common carp Cyprinus carpio, and cause the huge economic loss. To create the effective vaccine is the best way to control the outbreak of the disease caused by A. hydrophila. In this study, a live attenuate...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2016.04.075

    authors: Jiang X,Zhang C,Zhao Y,Kong X,Pei C,Li L,Nie G,Li X

    更新日期:2016-06-08 00:00:00

  • Feasibility of using regional sentinel surveillance to monitor the rotavirus vaccine impact, effectiveness and intussusception incidence in the African Region.

    abstract::The 9th African rotavirus symposium was held in Maputo, Mozambique from the 8th to 10th of December 2015, including a total of 101 delegates from 17 countries, 15 of which were African countries. This forum brought together participants with various expertise including scientists, clinicians, immunization program mana...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2017.01.072

    authors: Mandomando I,Weldegebriel G,de Deus N,Mwenda JM

    更新日期:2017-03-23 00:00:00

  • QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans.

    abstract::Three separate studies were undertaken in HIV-1 uninfected persons to determine if the adjuvant QS-21 improves the magnitude or kinetics of immune responses induced by recombinant soluble gp120 HIV-1(MN) protein (rsgp120) immunization. The QS-21 was administered at two doses (50 and 100 microg), either alone or in com...

    journal_title:Vaccine

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/s0264-410x(00)00415-1

    authors: Evans TG,McElrath MJ,Matthews T,Montefiori D,Weinhold K,Wolff M,Keefer MC,Kallas EG,Corey L,Gorse GJ,Belshe R,Graham BS,Spearman PW,Schwartz D,Mulligan MJ,Goepfert P,Fast P,Berman P,Powell M,Francis D,NIAID AIDS V

    更新日期:2001-02-28 00:00:00

  • Complement and antibodies: a dangerous liaison in HIV infection?

    abstract::Due to ongoing recombination and mutations, HIV permanently escapes from neutralizing antibody (nAb) responses of the host. By the masking of epitopes or shedding of gp120, HIV-1 further impedes an efficient neutralization by Abs. Therefore, nAbs responses of the host are chasing behind a rapidly evolving virus and ma...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2008.11.050

    authors: Stoiber H,Soederholm A,Wilflingseder D,Gusenbauer S,Hildgartner A,Dierich MP

    更新日期:2008-12-30 00:00:00

  • A short report on the highlights of world-wide development of RIX4414: a North American experience comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine (RIX4414) in infants in the United Sta

    abstract::This randomized, double-blind trial conducted in the US and Canada was conducted to compare the safety and immunogenicity of two dosages of live attenuated oral monovalent G1 human rotavirus (HRV) vaccine administered orally at a 2-month interval concomitantly with routine childhood vaccines to healthy infants 5-15 we...

    journal_title:Vaccine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.vaccine.2005.07.030

    authors: Dennehy PH,North American Human Rotavirus Vaccine Study Group.

    更新日期:2006-05-01 00:00:00

  • Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine.

    abstract::The current human whole-cell vaccine is ineffective against pneumonic plague caused by typical F1 capsule positive (F1+) strains of Yersinia pestis. The authors found this vaccine to also be ineffective against F1-negative (F1-) Y. pestis strains, which have been isolated from a human case and from rodents. For these ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(98)80110-2

    authors: Heath DG,Anderson GW Jr,Mauro JM,Welkos SL,Andrews GP,Adamovicz J,Friedlander AM

    更新日期:1998-07-01 00:00:00

  • Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1 associated immune response.

    abstract::The development of a vaccine for Helicobacter pylori is a key strategy for reducing the worldwide prevalence of H. pylori infection. Although immunization with recombinant B subunit of H. pylori urease (ureB) has yielded promising results, for the most part, these studies relied on the use of strong adjuvant, cholera ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(99)00035-3

    authors: Novak MJ,Smythies LE,McPherson SA,Smith PD,Morrow CD

    更新日期:1999-05-14 00:00:00

  • Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres.

    abstract::The development of a safe and effective vaccine against enterotoxigenic Escherichia coli (ETEC) would be useful for travellers and for young children in endemic areas. A feasibility study of an enteral ETEC vaccine prototype consisting of colonization factor antigen II (CFA/II), containing two component antigens CS1 a...

    journal_title:Vaccine

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0264-410x(94)80038-2

    authors: Tacket CO,Reid RH,Boedeker EC,Losonsky G,Nataro JP,Bhagat H,Edelman R

    更新日期:1994-11-01 00:00:00

  • Efficacy of a novel inactivated Lawsonia intracellularis vaccine in pigs against experimental infection and under field conditions.

    abstract::The efficacy of a novel inactivated Lawsonia intracellularis vaccine, Porcilis® Lawsonia, was compared to that of a commercially available live attenuated vaccine in three experimental vaccination-challenge studies in pigs. The efficacy of the new vaccine was further tested under field conditions on a farm with a hist...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2019.02.067

    authors: Jacobs AAC,Harks F,Hazenberg L,Hoeijmakers MJH,Nell T,Pel S,Segers RPAM

    更新日期:2019-04-03 00:00:00

  • Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease.

    abstract::In this study, West Nile virus (WNV) envelope (rE) protein and its domain III (rDIII) were efficiently expressed in a cost-effective system based on insect larvae as non-fermentative living biofactories. Mice immunized with the partially purified rE or rDIII elicited high antibodies titers that neutralized viral infec...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2010.12.081

    authors: Alonso-Padilla J,de Oya NJ,Blázquez AB,Escribano-Romero E,Escribano JM,Saiz JC

    更新日期:2011-02-17 00:00:00

  • Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines.

    abstract::Chikungunya virus is an emerging pathogen initially found in East Africa and currently spread into the Indian Ocean Islands, many regions of South East Asia, and in the Americas. No licensed vaccines against this eminent pathogen are available and thus intensive research in this field is a priority. This review presen...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2015.05.104

    authors: Salazar-González JA,Angulo C,Rosales-Mendoza S

    更新日期:2015-07-17 00:00:00

  • Smallpox and its eradication in the Democratic Republic of Congo: lessons learned.

    abstract::Smallpox eradication is considered to be one of the most remarkable accomplishments of the 20th century. Lessons learned from the campaign during the 1960s and 1970s in the Democratic Republic of Congo (DRC) can provide important information for the development of other eradication programs including polio. The DRC is...

    journal_title:Vaccine

    pub_type: 历史文章,杂志文章,评审

    doi:10.1016/j.vaccine.2011.10.049

    authors: Muyembe-Tamfum JJ,Mulembakani P,Lekie RB,Szczeniowski M,Ježek Z,Doshi R,Hoff N,Rimoin AW

    更新日期:2011-12-30 00:00:00

  • Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of innovation theories.

    abstract::To evaluate primary care physicians' attitude towards implementation of rotavirus (RV) immunisation into the Swiss immunisation schedule, an eight-question internet-based questionnaire was sent to the 3799 subscribers of InfoVac, a nationwide web-based expert network on immunisation issues, which reaches >95% of paedi...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2009.05.097

    authors: Agyeman P,Desgrandchamps D,Vaudaux B,Berger C,Diana A,Heininger U,Siegrist CA,Aebi C

    更新日期:2009-07-30 00:00:00

  • Vaccines against Ebola virus.

    abstract::We have just witnessed the largest and most devastating outbreak of Ebola virus disease, which highlighted the urgent need for development of an efficacious vaccine that could be used to curtail future outbreaks. Prior to 2014, there had been limited impetus worldwide to develop a vaccine since the virus was first dis...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2017.07.054

    authors: Venkatraman N,Silman D,Folegatti PM,Hill AVS

    更新日期:2018-08-28 00:00:00

  • Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990-2014.

    abstract::Hepatitis B infections are responsible for more than 300 thousand deaths per year in the Western Pacific Region. Because of this high burden, the countries and areas of the Region established a goal of reducing hepatitis B chronic infection prevalence among children to less than 1% by 2017. This study was conducted to...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2016.03.060

    authors: Wiesen E,Diorditsa S,Li X

    更新日期:2016-05-27 00:00:00

  • Healthy individuals' immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine.

    abstract::Crimean-Congo hemorrhagic fever virus (CCHFV) poses a great threat to public health due to its high mortality and transmission rate and wide geographical distribution. There is currently no specific antiviral therapy for CCHF. This study provides the first in-depth analysis of the cellular and humoral immune response ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2012.08.003

    authors: Mousavi-Jazi M,Karlberg H,Papa A,Christova I,Mirazimi A

    更新日期:2012-09-28 00:00:00

  • Differences between vaccinated and unvaccinated women explain increase in non-vaccine-type human papillomavirus in unvaccinated women after vaccine introduction.

    abstract::The aim of this study was to determine whether an observed increase in non-vaccine-type human papillomavirus (HPV) in unvaccinated women during the first eight years after vaccine introduction may be explained by differences in demographics or sexual behaviors, instead of type replacement. We analyzed data from three ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2017.11.005

    authors: Ding L,Widdice LE,Kahn JA

    更新日期:2017-12-19 00:00:00

  • Combination vaccines in the South African setting.

    abstract::The number of vaccines available and included as part of the national immunization schedules, has increased significantly over the past few decades. This impacts on patient/parent compliance and creates a challenge for health care providers for implementation of schedules necessitating training and infrastructure impr...

    journal_title:Vaccine

    pub_type: 杂志文章,评审

    doi:10.1016/j.vaccine.2012.05.001

    authors: Visser A,Hoosen A

    更新日期:2012-09-07 00:00:00

  • Oral polio vaccination and low case fatality at the paediatric ward in Bissau, Guinea-Bissau.

    abstract::Oral polio vaccine (OPV) and diphtheria-tetanus-pertussis (DTP) vaccines are given simultaneously in routine immunisation programmes in developing countries. It is therefore difficult to determine the separate effects of these vaccines on survival. We used the shortage of DTP vaccine in Bissau to examine the impact of...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2004.02.009

    authors: Aaby P,Rodrigues A,Biai S,Martins C,Veirum JE,Benn CS,Jensen H

    更新日期:2004-08-13 00:00:00

  • Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens.

    abstract::Plasmodium vivax is the second most common agent of human malaria. Although infection is rarely fatal, it nonetheless imposes a significant burden of illness in endemic areas. A successful vaccine against P. vivax will likely need to induce immune responses against both pre-erythrocytic and erythrocytic stage forms of...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/s0264-410x(99)00146-2

    authors: Rogers WO,Gowda K,Hoffman SL

    更新日期:1999-08-06 00:00:00

  • Comparison of prophylactic and therapeutic immunisation with an ErbB-2 (HER2) fusion protein and immunoglobulin V-gene repertoire analysis in a transgenic mouse model of spontaneous breast cancer.

    abstract::ErbB-2 is associated with several solid tumours of which breast cancer is the commonest cancer in women worldwide. Though anti-ErbB-2 antibody appears to play a significant role in prevention and therapy, naturally occurring anti-ErbB-2 antibody associated with the cleaved ectodomain of overexpressed ErbB-2 self antig...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2013.10.077

    authors: Mukhopadhyay A,Dyring C,Stott DI

    更新日期:2014-02-12 00:00:00

  • Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

    abstract::The ability of Escherichia coli heat-labile enterotoxin (LT) to influence the induction and maintenance of tolerance was examined in animals primed orally with a soluble protein antigen, ovalbumin (OVA), or in animals primed orally with two unrelated protein antigens administered simultaneously, OVA and bovine serum a...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/0264-410x(88)90223-x

    authors: Clements JD,Hartzog NM,Lyon FL

    更新日期:1988-06-01 00:00:00

  • Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.

    abstract::Vaccination strategies against Klebsiella pneumoniae have largely focussed on the polysaccharide capsule. However, the large number and high prevalence of individual capsular serotypes limits the widespread applicability of capsule-based vaccines. This study establishes that immunization with purified LPS can protect ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2008.07.100

    authors: Clements A,Jenney AW,Farn JL,Brown LE,Deliyannis G,Hartland EL,Pearse MJ,Maloney MB,Wesselingh SL,Wijburg OL,Strugnell RA

    更新日期:2008-10-16 00:00:00

  • The efficacy of recombinant turkey herpesvirus vaccines targeting the H5 of highly pathogenic avian influenza virus from the 2014-2015 North American outbreak.

    abstract::The outbreak of highly pathogenic avian influenza virus in North American poultry during 2014 and 2015 demonstrated the devastating effects of the disease and highlighted the need for effective emergency vaccine prevention and control strategies targeted at currently circulating strains. This study evaluated the effic...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2017.11.026

    authors: Balzli CL,Bertran K,Lee DH,Killmaster L,Pritchard N,Linz P,Mebatsion T,Swayne DE

    更新日期:2018-01-02 00:00:00

  • The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England.

    abstract:BACKGROUND:In the immunisation schedule in England and Wales, the 7-valent pneumococcal conjugate vaccine (PCV-7) was replaced by the 13-valent vaccine (PCV-13) in April 2010 after having been used since September 2006. The introduction of PCV-7 was informed by a cost effectiveness analysis using an infectious disease ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2012.10.017

    authors: van Hoek AJ,Choi YH,Trotter C,Miller E,Jit M

    更新日期:2012-11-26 00:00:00

  • Genetic immunization with GPI-anchored anthrax protective antigen raises combined CD1d- and MHC II-restricted antibody responses by natural killer T cell-mediated help.

    abstract::Studies have demonstrated that lipid rafts ultimately regulate the endocytosis of anthrax toxin via clathrin dependent pathway. Interestingly, GPI-anchored protein rich rafts have also been shown to be transported down to the endocytic pathway to reducing late endosomes. Taking advantage of this parallelism, we tried ...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2009.01.042

    authors: Midha S,Bhatnagar R

    更新日期:2009-03-10 00:00:00

  • Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutations.

    abstract::Protein C deletion mutants of West Nile virus (WNV) were evaluated for their potential use as live virus vaccine candidates in vivo. Double and triple mutants carrying small deletions and second-site point mutations, as well as mutants with large deletions of 36 and 37 amino acid residues were tested in a stringent mo...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2010.06.045

    authors: Schlick P,Kofler RM,Schittl B,Taucher C,Nagy E,Meinke A,Mandl CW

    更新日期:2010-08-16 00:00:00

  • Routing dependent immune responses after experimental R848-adjuvated vaccination.

    abstract::Most traditional vaccines are administered via the intramuscular route. Other routes of administration however, can induce equal or improved protective memory responses and might provide practical advantages such as needle-free immunization, dose sparing and induction of tissue-specific (mucosal) immunity. Here we exp...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/j.vaccine.2018.01.077

    authors: van Aalst S,Jansen MAA,Ludwig IS,van der Zee R,van Eden W,Broere F

    更新日期:2018-03-07 00:00:00

  • Use of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies.

    abstract::The vaccination of wild animals against rabies has been developed most extensively in Europe. Experiments have demonstrated the efficacy of a vaccinia-rabies recombinant virus administered by the oral route in foxes. The innocuity of this vaccine was tested in the target species as well as in several non-target wild a...

    journal_title:Vaccine

    pub_type: 杂志文章

    doi:10.1016/0264-410x(90)90129-a

    authors: Brochier B,Thomas I,Bauduin B,Leveau T,Pastoret PP,Languet B,Chappuis G,Desmettre P,Blancou J,Artois M

    更新日期:1990-04-01 00:00:00